Health & Wellbeing

Drug Testing & Analysis Podcast - a viable test for hGH?

Drug Testing & Analysis Podcast - a viable test for hGH?
The front cover of the first issue of the new magazine Drug Testing Analysis
The front cover of the first issue of the new magazine Drug Testing Analysis
View 1 Image
The front cover of the first issue of the new magazine Drug Testing Analysis
1/1
The front cover of the first issue of the new magazine Drug Testing Analysis

February 18, 2009 As the incidence of drugs escalates in 21st century living, their detection and analysis have become increasingly important. Sport, the workplace, crime investigation, homeland security, the pharmaceutical industry and the environment are just some of the high profile arenas in which analytical testing has provided an important investigative tool for uncovering the presence of extraneous substances. Now there's a new scientific magazine entitled Drug Testing and Analysis which will explore the analytical techniques used to determine controlled and potentially controversial compounds. As a promotion for the first issue, publishers Wiley-Blackwell have made public a podcast of an interview with Professor Richard Holt of the University of Southampton on the current state of human Growth Hormone use, abuse and detection in sports.

In addition to the usual publishing fare of primary research articles, case reports and letters, Drug Testing and Analysis offers a unique combination of; ‘How to’ material such as ‘Tutorials’ and ‘Reviews’, Speculative pieces (‘Commentaries’ and ‘Perspectives', providing a broader scientific and social context to the aspects of analytical testing), ‘Annual banned substance reviews’ (delivering a critical evaluation of the methods used in the characterization of established and newly outlawed compounds) and a bibliographical listing that pulls together all of the current literature in the field on a bimonthly basis.

The journal can be found online at drugtestinganalysis.com and the podcast can be accessed here.

No comments
0 comments
There are no comments. Be the first!